Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Celgene Corp (CELG US)
Watchlist
78
Analysis
Health Care
•
United States
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Jardine Matheson
•
10 Mar 2019 09:17
Last Week in Event SPACE: MYOB, Lynas, Versum, Jardines
Last Week in Event SPACE ... Not a bad reward/risk as Manikay greenmails KKR's MYOB Group Ltd (MYO AU) offer. If the Malaysian government impasse...
David Blennerhassett
Follow
570 Views
Share
bullish
•
Bristol Myers Squibb Co
•
07 Mar 2019 12:30
•
Syndicated
Bristol Myers Squib & Celgene–Starboard Objections Addressed Today- Successful Deal Closure Probable
The proposed Bristol Myers Squibb Co (BMY US) & Celgene Corp (CELG US) transaction announced in the first week of 2019, garnered many sceptical...
ANTYA Investments
Follow
420 Views
Share
bullish
•
Celgene Corp
•
28 Feb 2019 16:28
M&A: A Round-Up of Deals in February 2019
For the month of February, thirteen new deals were discussed on Smartkarma with an overall deal size of US$12.3bn. This overall number includes the...
David Blennerhassett
Follow
919 Views
Share
bullish
•
Celgene Corp
•
01 Feb 2019 15:21
M&A: A Round-Up of Deals in January 2019
For the month of January, seventeen new deals were discussed on Smartkarma with an overall deal size of US$91bn, with ~81% of that figure from the...
David Blennerhassett
Follow
1.3k Views
Share
bullish
•
Bank Danamon Indonesia
•
27 Jan 2019 09:18
Last Week in Event SPACE: Renault/Nissan, Bank Danamon, Kabu, Celgene, Intouch
Last Week in Event SPACE ... The eventual unwind of tension may involve an increase in Nissan Motor (7201 JP)'s stake in Renault SA (RNO FP) and a...
David Blennerhassett
Follow
1.1k Views
Share
First
Previous
10
11
12
13
14
15
16
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x